Evidence map›Paper›PMID 36310880›Full record

ArticleFrontiers in cellular and infection microbiology2022

Wei Zhao, Xinxin Li, Qi Yang, Longcan Zhou, Mengxi Duan, Maohua Pan, Yucheng Qin, Xiaosong Li, Xun Wang, Weilin Zeng and 10 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. JAC-antimicrobial resistance · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 3 countries.

Wei ZhaoDepartment of Pathogen Biology and Immunology, Kunming Medical University, Kunming, China.
Xinxin LiDepartment of Pathogen Biology and Immunology, Kunming Medical University, Kunming, China.
Qi YangDepartment of Pathogen Biology and Immunology, Kunming Medical University, Kunming, China.
Longcan ZhouDepartment of Infectious Diseases, Shanglin County People's Hospital, Guangxi, China.
Mengxi DuanDepartment of Pathogen Biology and Immunology, Kunming Medical University, Kunming, China.
Maohua PanDepartment of Infectious Diseases, Shanglin County People's Hospital, Guangxi, China.
Yucheng QinDepartment of Infectious Diseases, Shanglin County People's Hospital, Guangxi, China.
Xiaosong LiDepartment of Pathogen Biology and Immunology, Kunming Medical University, Kunming, China.
Xun WangDepartment of Pathogen Biology and Immunology, Kunming Medical University, Kunming, China.
Weilin ZengDepartment of Pathogen Biology and Immunology, Kunming Medical University, Kunming, China.
Hui ZhaoDepartment of Pathogen Biology and Immunology, Kunming Medical University, Kunming, China.
Kemin SunDepartment of Pathogen Biology and Immunology, Kunming Medical University, Kunming, China.
Wenya ZhuDepartment of Pathogen Biology and Immunology, Kunming Medical University, Kunming, China.
Yaw AfraneDepartment of Medical Microbiology, College of Health Sciences, University of Ghana, Accra, Ghana.
Linda Eva AmoahNoguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.
Benjamin AbuakuNoguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.
Nancy Odurowah Duah-QuashieNoguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.
Yaming HuangDepartment of Protozoan Diseases, Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Nanning, China.
Liwang CuiDepartment of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, United States.
Zhaoqing YangDepartment of Pathogen Biology and Immunology, Kunming Medical University, Kunming, China.
Kunming Medical University · CNUniversity of Ghana · GHGuangxi Center for Disease Prevention and Control · CNNoguchi Memorial Institute for Medical Research · GHUniversity of South Florida · US

Funding

Southeast Asia Malaria Research CenterU19AI089672 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI CUI, LIWANG · 2010 to 2023
$28.9M
NIAID NIH HHS U19 AI089672
6 · The paper itself

Abstract

Drug resistance in

Indexed as

AntimalarialsMalaria, FalciparumArtemetherArtemether, Lumefantrine Drug CombinationChloroquineGhanaHumansLumefantrinePlasmodium falciparumProtozoan ProteinsPyrimethamineAntimalarialsArtemetherArtemether, Lumefantrine Drug CombinationChloroquineLumefantrineProtozoan ProteinsPyrimethaminedrug resistancegenetic polymorphismin vitro assaymalaria parasitering survival assayWest Africa

Identifiers

PMID36310880
PMCPMC9614232
OpenAlexW4306160248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.